2017


To access this material please log in or register

Register Authorize
2017/№S1

Correlations of IL-18 and IL-6 with sodium consumption in patients with arterial hypertension and diabetes mellitus

Dragunov D. O., Sokolova A. V., Arutyunov G. P., Mitrokhin V. M., Kamkin A. G., Latyshev T. V.
Pirogov Russian National Research Medical University, Ostrovityanova 1, Moscow 117997

Keywords: interleukin-18, interleukin-6, hypertension, diabetes mellitus, sodium consumption

DOI: 10.18087/cardio.2389

Aim. To determine correlations of AH-associated interleukins (IL-18, IL-6) with sodium consumption in AH patients with and without DM. Materials and methods. The study included AH patients with and without DM (n=63) who were managed at the Municipal Clinic #64, Moscow Department of Health Care, Branch 1. Plasma levels of IL-6 and IL-18 were measured using ELISA kits (Bender Med-Systems). Salt consumption was determined using a Charlton: SaltScreener questionnaire. Statistical analyses were performed using the Statistica 10.0 software. Results. Four groups were formed: Group 1, grade 2 AH and DM (n=19); Group 2, grade 2 AH and no DM (n=4); Group 3, grade 3 AH and no DM (n=28); and Group 4, grade 3 AH and DM (n=12). Group 2 was small and was excluded from further analysis due to impossibility of statistical treatment. All patients consumed more than 6 g of salt per day (approximately 10 g). Analysis of intergroup differences in selected parameters showed differences between groups in levels of cholesterol, triglycerides, LDL, and GFR. The following correlations were identified in the groups: Group 1, positive correlation of IL-18 with sodium consumption (r=0.65) and CRP level (r=0.52) and of IL-6 with LDL level (r=0.48); Group 3, positive correlation of IL-18 with IL-6 (r=0.66) and of IL-6 with CRP (r=0.52); Group 4, positive correlation of IL-18 with GFR (r=0.82) and of IL-6 with waist circumference (WC) (r=0.84) and IL-6 (r=0.73). Conclusion. Patients consuming more than 6 g of salt daily (approximately 10 g) with AH and DM had more pronounced inflammation, which promoted progression of kidney disease.
  1. Valente AJ, Yoshida T, Murthy SN, Sakamuri SSVP, Katsuyama M, Clark RA et al. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. AJP: Heart and Circulatory Physiology. 2012;303(3):H282–96. DOI:10.1152/ajpheart.00231.2012.
  2. Haller H, Park JK, Dragun D, Lippoldt A, Luft FC. Leukocyte infiltration and ICAM-1 expression in two-kidney one-clip hypertension. Nephrol Dial Transplant. 1997;12(5):899–903.
  3. Boos CJ, Lip GYH. Is hypertension an inflammatory process? Curr Pharm Des. 2006;12(13):1623–35.
  4. Li Q, Deng Q, Li J, Yi G, Zhao S. Valsartan reduces interleukin-1β secretion by peripheral blood mononuclear cells in patients with essential hypertension. Clinica Chimica Acta. 2005;355(1–2):131–6. DOI:10.1016/j.cccn.2004.12.006.
  5. Cahill CM, Rogers JT. Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/IκB Kinase α Pathway Targeting Activator Protein-1. Journal of Biological Chemistry. 2008;283(38):25900–12. DOI:10.1074/jbc.M707692200.
  6. Charlton KE, Steyn K, Levitt NS, Jonathan D, Zulu JV, Nel JH. Development and validation of a short questionnaire to assess sodium intake. Public Health Nutrition [Internet]. 2008;11(01). Available from: http://www.journals.cambridge.org/abstract_S1368980007000146 DOI:10.1017/S1368980007000146.
  7. Арутюнов Г. П., Драгунов Д. О., Соколова А. В. Взаимосвязь между натрийурезом, показателями центральной гемодинамики и плазменной концентрацией ангиотензина II. Клиническая нефрология. 2013;(6):24–8 [Arutyunov G. P., Dragunov D. O., Sokolova A. V. Vzaimosvyaz` mezhdu natrijurezom, pokazatelyami czentral`noj gemodinamiki i plazmennoj konczentracziej angiotenzina II. Klinicheskaya nefrologiya. 2013;(6):24–8].
  8. Арутюнов Г. П., Оганезова Л. Г., Драгунов Д. О., Соколова А. В. Эпидемиология артериальной гипертензии: ее взаимосвязь с поражением почек и феноменом соль-чувствительности. Клиническая нефрология. 2013;(2):67–72 [Arutyunov G. P., Oganezova L. G., Dragunov D. O., Sokolova A. V. E`pidemiologiya arterial`noj gipertenzii: ee vzaimosvyaz` s porazheniem pochek i fenomenom sol`-chuvstvitel`nosti. Klinicheskaya nefrologiya. 2013;(2):67–72]
  9. Арутюнов Г. П., Костюкевич О. И., Хадышьян Г. Г. Немедикаментозные методы коррекции системного воспаления при заболеваниях сердечно-сосудистой системы. Сердце: журнал для практикующих врачей. 2005;4(5):268 [Arutyunov G. P., Kostyukevich O. I., Xady`sh`yan G. G. Nemedikamentozny`e metody` korrekczii sistemnogo vospaleniya pri zabolevaniyax serdechno-sosudistoj sistemy`. Serdcze: zhurnal dlya praktikuyushhix vrachej. 2005;4(5):268].
  10. Арутюнов Г. П., Драгунов Д. О., Соколова А. В. Оценка влияния петлевых диуретиков с разными периодами полувыведения на ретенцию натрия. Клиническая нефрология. 2013;(5):8–12 [Arutyunov G. P., Dragunov D. O., Sokolova A. V. Oczenka vliyaniya petlevy`x diuretikov s razny`mi periodami poluvy`vedeniya na retencziyu natriya. Klinicheskaya nefrologiya. 2013;(5):8–12].
  11. Ярилин А. А. Основы иммунологии. М.: Медицина; 1999. 608 с [Yarilin A. A. Osnovy` immunologii. M.: Mediczina; 1999. 608 s].
  12. Галактионов В. Г. Иммунология. М.: Нива России; 2000. 488 с [Galaktionov V. G. Immunologiya. M.: Niva Rossii; 2000. 488 s].
  13. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res. 2002;4 Suppl 3:S233-242. DOI:10.1186/ar565.
  14. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27(3):813–23.
  15. Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes. 2005;54 Suppl 2:S114-124.
  16. Franckhauser S, Elias I, Rotter Sopasakis V, Ferré T, Nagaev I, Andersson CX et al. Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia. 2008;51(7):1306–16. DOI:10.1007/s00125-008-0998-8.
  17. Sopasakis VR, Sandqvist M, Gustafson B, Hammarstedt A, Schmelz M, Yang X et al. High Local Concentrations and Effects on Differentiation Implicate Interleukin-6 as a Paracrine Regulator. Obesity Research. 2004;12(3):454–60. DOI:10.1038/oby.2004.51.
  18. González GE, Rhaleb N-E, Nakagawa P, Liu Y-H, Carretero OA. Abstract 446: Deletion of Il-6 Prevents Development of Cardiac Damage and Dysfunction in Chronic Ang Ii-salt-induced Hypertension. Hypertension. 2015;60(Suppl 1):A446.
  19. Crosswhite P, Sun Z. Ribonucleic Acid Interference Knockdown of Interleukin 6 Attenuates Cold-Induced Hypertension. Hyper tension. 2010;55(6):1484–91. DOI:10.1161/HYPERTENSIONAHA.109.146902.
  20. Sugama S, Conti B. Interleukin-18 and stress. Brain Research Reviews. 2008;58(1):85–95. DOI:10.1016/j.brainresrev.2007.11.003.
  21. Johanna Ojala, Elina Sutinen. The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer’s Disease. Journal of Clinical Medicine. 2017;6(6):55. DOI:10.3390/jcm6050055.
  22. Rabkin SW. The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease. Nature Clinical Practice Cardiovascular Medicine. 2009;6(3):192–9. DOI:10.1038/ncpcardio1453.
  23. Chang C-H, Fan P-C, Lin C-Y, Yang C-H, Chen Y-T, Chang S-W et al. Elevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events. Medicine. 2015;94:e1836. DOI:10.1097/MD.0000000000001836.
Dragunov D. O., Sokolova A. V., Arutyunov G. P., Mitrokhin V. M., Kamkin A. G., Latyshev T. V. Correlations of IL-18 and IL-6 with sodium consumption in patients with arterial hypertension and diabetes mellitus. Kardiologiia. 2017;57(S1):355–359

To access this material please log in or register

Register Authorize
Ru En